160 related articles for article (PubMed ID: 34182479)
1. Significant Association of Cyclin D1 Promoter Genotypes With Asthma Susceptibility in Taiwan.
Li CH; Chiu KL; Hsia TC; Shen TC; Chen LH; Yu CC; Mong MC; Chang WS; Tsai CW; Bau DT
In Vivo; 2021; 35(4):2041-2046. PubMed ID: 34182479
[TBL] [Abstract][Full Text] [Related]
2. The significant association of CCND1 genotypes with gastric cancer in Taiwan.
Kuo HW; Huang CY; Fu CK; Liao CH; Hsieh YH; Hsu CM; Tsai CW; Chang WS; Bau DT
Anticancer Res; 2014 Sep; 34(9):4963-8. PubMed ID: 25202078
[TBL] [Abstract][Full Text] [Related]
3. Significant Association of
Hsu PC; Pei JS; Chen CC; Chang WS; Chin YT; Huang TL; Yang JS; Wang YC; Chen JC; Hsu YN; Tsai CW; Bau DT
Anticancer Res; 2021 Oct; 41(10):4801-4806. PubMed ID: 34593429
[TBL] [Abstract][Full Text] [Related]
4. The significant association of CCND1 genotypes with colorectal cancer in Taiwan.
Huang CY; Tsai CW; Hsu CM; Chang WS; Shui HA; Bau DT
Tumour Biol; 2015 Aug; 36(8):6533-40. PubMed ID: 25809706
[TBL] [Abstract][Full Text] [Related]
5. Interaction of CCND1 genotype and smoking habit in Taiwan lung cancer patients.
Hsia TC; Liu CJ; Lin CH; Chang WS; Chu CC; Hang LW; Lee HZ; Lo WC; Bau DT
Anticancer Res; 2011 Oct; 31(10):3601-5. PubMed ID: 21965784
[TBL] [Abstract][Full Text] [Related]
6. Association of cyclin D1 genotypes with nasopharyngeal carcinoma risk.
Shih LC; Tsai CW; Tsai MH; Tsou YA; Chang WS; Li FJ; Lee MH; Bau DT
Anticancer Res; 2012 Mar; 32(3):1093-8. PubMed ID: 22399638
[TBL] [Abstract][Full Text] [Related]
7. The association of a variant in the cell cycle control gene CCND1 and obesity on the development of asthma in the Swiss SAPALDIA study.
Thun GA; Imboden M; Berger W; Rochat T; Probst-Hensch NM
J Asthma; 2013 Mar; 50(2):147-54. PubMed ID: 23311506
[TBL] [Abstract][Full Text] [Related]
8. Association between
Thakur N; Kumari S; Mehrotra R
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30361291
[No Abstract] [Full Text] [Related]
9. Association of CCND1 rs9344 polymorphism with lung cancer susceptibility and clinical outcomes: a case-control study.
Mei C; Wang T; Xu B; Wu S; Zhang X; Lv Y; Zhang Y; Liu Z; Gong W
BMC Pulm Med; 2024 Apr; 24(1):167. PubMed ID: 38589850
[TBL] [Abstract][Full Text] [Related]
10. Significant association of cyclin D1 single nucleotide polymorphisms with oral cancer in taiwan.
Tsai MH; Tsai CW; Tsou YA; Hua CH; Hsu CF; Bau DT
Anticancer Res; 2011 Jan; 31(1):227-31. PubMed ID: 21273603
[TBL] [Abstract][Full Text] [Related]
11. Association Between Polymorphism rs678653 in Human Cyclin D1 Gene (CCND1) and Susceptibility to Cancer: A Meta-Analysis.
Dai X; Zhang X; Wang B; Wang C; Jiang J; Wu C
Med Sci Monit; 2016 Mar; 22():863-74. PubMed ID: 26979757
[TBL] [Abstract][Full Text] [Related]
12. Potential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in Taiwan.
Lin HH; Ke HL; Hsiao KH; Tsai CW; Wu WJ; Bau DT; Chang LL
Chin J Physiol; 2011 Jun; 54(3):196-202. PubMed ID: 21789902
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage.
Koike H; Suzuki K; Satoh T; Ohtake N; Takei T; Nakata S; Yamanaka H
Anticancer Res; 2003; 23(6D):4947-51. PubMed ID: 14981950
[TBL] [Abstract][Full Text] [Related]
14. Significance of cyclin D1 polymorphisms in patients with head and neck cancer.
Sabir M; Baig RM; Mahjabeen I; Kayani MA
Int J Biol Markers; 2013 Apr; 28(1):49-55. PubMed ID: 23125009
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.
Wang L; Habuchi T; Takahashi T; Mitsumori K; Kamoto T; Kakehi Y; Kakinuma H; Sato K; Nakamura A; Ogawa O; Kato T
Carcinogenesis; 2002 Feb; 23(2):257-64. PubMed ID: 11872630
[TBL] [Abstract][Full Text] [Related]
16. Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley: a high risk area.
Hussain S; M Y; Thakur N; Salam I; Singh N; Mir MM; Bhat MA; Siddiqi MA; Das BC; Bharadwaj M
Mol Carcinog; 2011 Jul; 50(7):487-98. PubMed ID: 21268129
[TBL] [Abstract][Full Text] [Related]
17. Association of CCND1 (c.723G > A, rs9344) variant with elevated risk of breast carcinoma: a retrospective case-control study.
El-Eshmawy MA; Shahin HE; El-Beltagy NS; Abdel Hamid D; Elfarargy OM; Elsayed DH; Elsaid AM; Elshazli RM; Mohamed NM
Mol Biol Rep; 2023 Mar; 50(3):2015-2024. PubMed ID: 36534235
[TBL] [Abstract][Full Text] [Related]
18. CCND1 rs9344 polymorphism is associated with the risk of hepatocellular carcinoma in Caucasian population.
Wang DD; Duan WD; Zhu ZM; Tu YL; Dou CQ; Han MM; Zhang B; Zhao W; Jiang K
J Cancer Res Ther; 2018 Jun; 14(Supplement):S516-S518. PubMed ID: 29970717
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 gene polymorphism and susceptibility to childhood acute lymphoblastic leukemia in a Chinese population.
Hou X; Wang S; Zhou Y; Xu Z; Zou Y; Zhu X; Han M; Pang T; Han ZC
Int J Hematol; 2005 Oct; 82(3):206-9. PubMed ID: 16207592
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study.
Zheng Y; Shen H; Sturgis EM; Wang LE; Eicher SA; Strom SS; Frazier ML; Spitz MR; Wei Q
Carcinogenesis; 2001 Aug; 22(8):1195-9. PubMed ID: 11470749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
